Related Attributes
Product details
Troxerutin can inhibit erythrocyte and platelet agglutination, and at the same time can increase the blood oxygen content, improve microcirculation, and promote the formation of new blood vessels, it is a better treatment of occlusive cerebral blood vessels to protect the endothelial cells, and the treatment of acute ischemic brain injury; and anti-radiation injury, anti-inflammation, anti-allergy, and anti-ulcer and other effects. It is the main component of Vibramycin, often made into tablets and injections.
Uses and functions of Troxerutin.
Used as anticoagulant, with the effect of preventing thrombosis, applicable to cerebral thrombosis and cerebral embolism caused by hemiplegia, aphasia and myocardial infarction, arteriosclerosis, etc.
Troxerutin has the effects of anticoagulation and prevention of thrombosis, and is suitable for the treatment of hemiplegia, aphasia, arteriosclerosis, thrombophlebitis, varicose veins, chronic venous insufficiency, central retinitis, diabetic retinitis, and oedema caused by increased vascular permeability due to cerebral thrombosis.
Pharmacological Effects of Troxerutin.
Troxerutin can inhibit platelet aggregation and has the effect of preventing thrombosis. At the same time, it can counteract the vascular damage caused by 5-hydroxytryptamine and bradykinin, increase the resistance of capillaries, reduce the permeability of capillaries, and prevent oedema caused by the increase of vascular permeability.
Tricerutin (TiOxerutin) can inhibit platelet aggregation, and has the effect of preventing thrombosis. At the same time, it can counteract the vascular damage caused by 5-trans-tryptamine and bradykinin, increase capillary resistance and reduce capillary permeability, which can prevent oedema caused by elevated vascular permeability. It has significant protective effect on acute ischaemic brain injury.
Production method Bulk Troxerutin Powder.
Triclabrutin can be made into suitable soft material with starch as filler and 95% ethanol as wetting agent, granulated and dried and then rectified with nylon sieve bottom, and then pressed into tablets after mixing with magnesium stearate and talc as lubricant. Its appearance is smooth and delicate, the tablet hardness is good, the tablet weight difference is stable, and the content is qualified.
This process can improve the fluidity and outflow speed of Troxerutin powder, make the outflow speed of the particles fast flow rate uniformity, so as to ensure the stability of the tablet difference, and at the same time, the granulation can reduce the amount of fine powder, reduce the powder and the opportunity to contact with the punch rod, avoiding the phenomenon of pulling the mould. This process does not require drying less energy consumption, low cost, suitable for industrial production.
Why choose us?
HRK Factory
About Shipping
Pharmaceutical Intermediate manufacturers
©2022 Xi'an Henrikang Biotech Co., Ltd.,